<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Samarasinghe A</submitter><funding>National Health and Medical Research Council</funding><pagination>sfad245</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10926326</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Diabetes mellitus (DM) is associated with a greater risk of mortality in kidney transplant patients, primarily driven by a greater risk of cardiovascular disease (CVD)-related mortality. However, the associations between diabetes status at time of first allograft loss and mortality on dialysis remain unknown.&lt;h4>Methods&lt;/h4>All patients with failed first kidney allografts transplanted in Australia and New Zealand between 2000 and 2020 were included. The associations between diabetes status at first allograft loss, all-cause and cause-specific mortality were examined using competing risk analyses, separating patients with diabetes into those with pre-transplant DM or post-transplant diabetes mellitus (PTDM).&lt;h4>Results&lt;/h4>Of 3782 patients with a median (IQR) follow-up duration of 2.7 (1.1-5.4) years, 539 (14%) and 390 (10%) patients had pre-transplant DM or developed PTDM, respectively. In the follow-up period, 1336 (35%) patients died, with 424 (32%), 264 (20%) and 199 (15%) deaths attributed to CVD, dialysis withdrawal and infection, respectively. Compared to patients without DM, the adjusted subdistribution HRs (95% CI) for pre-transplant DM and PTDM for all-cause mortality on dialysis were 1.47 (1.17-1.84) and 1.47 (1.23-1.76), respectively; for CVD-related mortality were 0.81 (0.51-1.29) and 1.02 (0.70-1.47), respectively; for infection-related mortality were 1.84 (1.02-3.35) and 2.70 (1.73-4.20), respectively; and for dialysis withdrawal-related mortality were 1.71 (1.05-2.77) and 1.51 (1.02-2.22), respectively.&lt;h4>Conclusions&lt;/h4>Patients with diabetes at the time of kidney allograft loss have a significant survival disadvantage, with the excess mortality risk attributed to infection and dialysis withdrawal.</pubmed_abstract><journal>Clinical kidney journal</journal><pubmed_title>Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss.</pubmed_title><pmcid>PMC10926326</pmcid><funding_grant_id>1196033</funding_grant_id><pubmed_authors>Pilmore H</pubmed_authors><pubmed_authors>Ooi E</pubmed_authors><pubmed_authors>Hawley C</pubmed_authors><pubmed_authors>Lok C</pubmed_authors><pubmed_authors>Davies CE</pubmed_authors><pubmed_authors>Lim WH</pubmed_authors><pubmed_authors>Mulley WR</pubmed_authors><pubmed_authors>Polkinghorne KR</pubmed_authors><pubmed_authors>Larkins NG</pubmed_authors><pubmed_authors>Johnson DW</pubmed_authors><pubmed_authors>Teixeira-Pinto A</pubmed_authors><pubmed_authors>Roberts MA</pubmed_authors><pubmed_authors>Samarasinghe A</pubmed_authors><pubmed_authors>Wong G</pubmed_authors><pubmed_authors>Boudville N</pubmed_authors><pubmed_authors>Viecelli AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss.</name><description>&lt;h4>Background&lt;/h4>Diabetes mellitus (DM) is associated with a greater risk of mortality in kidney transplant patients, primarily driven by a greater risk of cardiovascular disease (CVD)-related mortality. However, the associations between diabetes status at time of first allograft loss and mortality on dialysis remain unknown.&lt;h4>Methods&lt;/h4>All patients with failed first kidney allografts transplanted in Australia and New Zealand between 2000 and 2020 were included. The associations between diabetes status at first allograft loss, all-cause and cause-specific mortality were examined using competing risk analyses, separating patients with diabetes into those with pre-transplant DM or post-transplant diabetes mellitus (PTDM).&lt;h4>Results&lt;/h4>Of 3782 patients with a median (IQR) follow-up duration of 2.7 (1.1-5.4) years, 539 (14%) and 390 (10%) patients had pre-transplant DM or developed PTDM, respectively. In the follow-up period, 1336 (35%) patients died, with 424 (32%), 264 (20%) and 199 (15%) deaths attributed to CVD, dialysis withdrawal and infection, respectively. Compared to patients without DM, the adjusted subdistribution HRs (95% CI) for pre-transplant DM and PTDM for all-cause mortality on dialysis were 1.47 (1.17-1.84) and 1.47 (1.23-1.76), respectively; for CVD-related mortality were 0.81 (0.51-1.29) and 1.02 (0.70-1.47), respectively; for infection-related mortality were 1.84 (1.02-3.35) and 2.70 (1.73-4.20), respectively; and for dialysis withdrawal-related mortality were 1.71 (1.05-2.77) and 1.51 (1.02-2.22), respectively.&lt;h4>Conclusions&lt;/h4>Patients with diabetes at the time of kidney allograft loss have a significant survival disadvantage, with the excess mortality risk attributed to infection and dialysis withdrawal.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-22T16:21:52.378Z</modification><creation>2025-04-06T01:42:24.569Z</creation></dates><accession>S-EPMC10926326</accession><cross_references><pubmed>38468698</pubmed><doi>10.1093/ckj/sfad245</doi></cross_references></HashMap>